Skip to content
Review Open access

OTULIN: a master regulator of linear ubiquitin homeostasis in immune signaling, inflammation, and disease

Aug 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 78 references
Medicine

TL;DR

A comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies are provided to inform future mechanistic studies and facilitate translational advances in targeted therapies.

Abstract

OTU deubiquitinase with linear linkage specificity (OTULIN) is the only deubiquitinase known to exhibit strict specificity for Met1-linked linear ubiquitin chains, serving as a critical regulator that restrains linear ubiquitin chain assembly complex and maintains inflammatory homeostasis and tissue integrity. Advances over recent years have reshaped our understanding of OTULIN from a negative regulator confined to the canonical nuclear factor kappa-light-chain-enhancer of activated B cells pathway to a central editor governing linear ubiquitin network homeostasis. Its functional repertoire spans receptor-proximal inflammatory signaling, cell death fate determination, inflammasome activation, autophagy, and cellular stress adaptation. Emerging evidence from human genetics and animal models has further broadened the OTULIN-associated disease spectrum, revealing that pathogenesis arises from imbalanced linear ubiquitin networks coupled with cell type and tissue context dependent inflammatory dysregulation. Here, we provide a comprehensive overview of OTULIN’s structural features, regulatory mechanisms, biological functions, roles in pathogenesis, and potential therapeutic intervention strategies, aiming to inform future mechanistic studies and facilitate translational advances in targeted therapies.

Read PDF

Similar papers

Review Open access Aug 2026

Deubiquitinating enzymes in kidney diseases: Molecular mechanisms, pathological roles and therapeutic opportunities (Review)

The ubiquitin-proteasome system maintains cellular protein turnover and quality control through the coordinated action of ubiquitin ligases and deubiquitinating enzymes (DUBs). While the functions of E3 ubiquitin ligases have been extensively investigated in renal disease, the ~100 human DUBs distributed across seven s...

Qianqian Li, Yufang Ni, Zhao-Yang Li et al. · 1 citation
Review Sep 2026

In the wisdom of Odin: modular architecture, receptor trafficking and therapeutic implications

A deeper understanding of Odin's structural organization and molecular mechanisms may not only reveal fundamental principles of receptor regulation but also establish Odin as a promising, yet largely unexplored, therapeutic target.

V. Pennacchietti, F. Malagrinò, S. Gianni · 0 citations
Review Open access Sep 2026

Regulatory roles of E3 ubiquitin ligase RNF128 in inflammatory diseases and tumors

Ring finger protein 128 (RNF128) belongs to the family of transmembrane E3 ubiquitin (Ub) ligases. It mediates substrate-specific ubiquitination as a critical post-translational modification and regulates diverse physiological activities and pathological processes. More importantly, the E3 Ub ligase RNF128 is involved...

Qiu-Xiang Xiao, Qi-Dong Liu, Jin-Can Wei et al. · 0 citations
Review Open access Sep 2026

UBA1 as a proteostasis-innate immunity checkpoint: lessons from vexas syndrome and therapeutic implications

It is proposed that UBA1 functions as a proteostasis-innate immunity checkpoint whose biological output is determined by residual enzymatic activity, subcellular distribution, lineage context, and clone size and suggests a mechanism-based approach to therapeutic intervention in VEXAS syndrome and malignancy.

Yan-Yu Zhang, Quan-Xin Su · 0 citations
Review Open access Aug 2026

MARCH E3 Ligases: Understudied Regulators of Pulmonary Immune Function

Membrane-associated RING-CH (MARCH) ligases are a family of 11 ubiquitin E3 ligases that regulate protein stability, trafficking, and signaling across diverse cellular contexts. Although MARCH ligases have been studied most extensively in immune regulation, antigen presentation, viral restriction, and cellular homeosta...

S. Speaks, Anthony Pastore, Mu-Chun Tsai · 0 citations
Review Open access Sep 2026

The ubiquitin-editing enzyme A20 (TNFAIP3): mechanisms of activation, biological function, diseases and therapeutic targets

A20 emerges as a context-dependent regulator of inflammation, tissue remodeling and tumour progression with relevance for biomarker development and precision therapeutic targeting and the therapeutic implications of A20 are assessed.

Jun-Ying Hu, Xing-Chen Liu, Wen-Qiao Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.